Viralgen offers specialized production of Adeno-Associated Virus (AAV) gene therapy vectors, using a proprietary suspension and triple transfection platform. Our scalable 2000L manufacturing process ensures high yield and quality, with full support from Drug Product Fill & Finish to regulatory compliance for preclinical and commercial needs.
